KeyCorp Upgrades Guardian Pharmacy Services (NYSE:GRDN) to Strong-Buy

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by research analysts at KeyCorp to a “strong-buy” rating in a report released on Tuesday, Zacks reports.

Several other equities research analysts also recently issued reports on the company. Truist Financial raised their price target on Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a research report on Monday. Bank of America increased their target price on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Oppenheimer lifted their price target on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Weiss Ratings raised Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Guardian Pharmacy Services presently has an average rating of “Buy” and a consensus target price of $45.57.

Guardian Pharmacy Services Trading Up 0.9%

Shares of Guardian Pharmacy Services stock opened at $44.57 on Tuesday. The firm has a fifty day simple moving average of $40.66 and a 200-day simple moving average of $39.06. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of 43.27, a PEG ratio of 2.29 and a beta of 0.06. Guardian Pharmacy Services has a 1-year low of $23.14 and a 1-year high of $48.33.

Guardian Pharmacy Services (NYSE:GRDN) last posted its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The business had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. As a group, research analysts predict that Guardian Pharmacy Services will post 1.19 earnings per share for the current year.

Institutional Trading of Guardian Pharmacy Services

Several institutional investors have recently bought and sold shares of GRDN. Jennison Associates LLC boosted its stake in shares of Guardian Pharmacy Services by 609.5% in the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after purchasing an additional 706,823 shares in the last quarter. Sei Investments Co. lifted its holdings in Guardian Pharmacy Services by 40.5% during the 1st quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after purchasing an additional 103,177 shares during the last quarter. Braun Stacey Associates Inc. acquired a new position in Guardian Pharmacy Services in the second quarter valued at about $14,234,000. Dimensional Fund Advisors LP grew its stake in Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after buying an additional 139,070 shares during the last quarter. Finally, Ranger Investment Management L.P. acquired a new stake in shares of Guardian Pharmacy Services during the second quarter worth approximately $7,263,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.